TMIC-06. DEFICIENCY OF Mirna-146A-5p CONTRIBUTES TO TRANSFORMATION OF GLIOMA-DERIVED MESENCHYMAL STROMAL/STEM CELLS VIA TARGETING HNRNPD

Jun Dong

DOI: https://doi.org/10.1093/neuonc/noy148.1066

2018-01-01

Neuro-Oncology

Abstract:Although malignant transformation of tumor stroma cells has been reported previously, its relevant mechanisms still kept largely unknown. In this study, we established three intracerebral xenograft tumor models byde novo transplanting glioma initiating cells and glioblastoma surgical specimens into cerebral cortex of the enhanced green fluorescent protein (EGFP) transgenic nude mice and chimeric nude mice. With dual color tracing techniques, which based on transfection of tumor cells with red fluorescent protein(RFP) and host cells bearing EGFP, three EGFP-expressing host bone marrow derived mesenchymal stromal cells (MSCs) were sorted from different intracerebral xenograft models, showing characteristics of immortality and malignant growth pattern. High-throughput RNA-sequencing of these cells results showed up-regulation of 19 miRNAs, and down-regulation of 24 miRNAs, respectively. MiRNA-146a-5p was one of the downregulated miRNAs, and overexpression of it can reverse malignant phenotype of transformed MSCs. Double-luciferase assay showed that miRNA-146a-5p directly acted on oncogene HNRNPD which was overexpressed in cancerous MSCs. SiRNA targeting HNRNPD could efficiently inhibit the proliferation of transformed cells and arrest the cell cycle at G2/M phase, and increase the apoptosis of cells. In summary, deficiency of miRNA-146a-5p contributes to the malignant transformation of host bone marrow derived mesenchymal stromal cells in the intracerebral xenograft tumors by overexpressing the tumorigenesis gene, HNRNPD.